STIFEL FINANCIAL CORP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$442,383
-19.2%
7,383
-2.8%
0.00%0.0%
Q2 2023$547,830
+68.9%
7,598
+72.3%
0.00%
Q1 2023$324,399
-55.8%
4,410
-40.3%
0.00%
-100.0%
Q4 2020$734,000
-2.8%
7,383
-7.0%
0.00%
-50.0%
Q3 2020$755,000
-7.0%
7,935
+9.3%
0.00%0.0%
Q2 2020$812,000
+155.3%
7,260
+66.2%
0.00%
+100.0%
Q1 2020$318,000
-95.9%
4,368
-94.1%
0.00%
-93.8%
Q4 2019$7,730,000
-1.0%
73,990
-6.5%
0.02%
-20.0%
Q3 2019$7,808,000
-37.9%
79,135
-27.8%
0.02%
-37.5%
Q2 2019$12,575,000
-1.4%
109,675
+8.7%
0.03%
-11.1%
Q1 2019$12,749,000
-7.6%
100,855
-0.6%
0.04%
-20.0%
Q4 2018$13,798,000
-40.6%
101,496
+19.9%
0.04%
-32.8%
Q3 2018$23,218,000
-6.7%
84,640
-29.5%
0.07%
-11.8%
Q2 2018$24,882,000
+27.5%
120,133
+1.5%
0.08%
+22.6%
Q1 2018$19,518,000
+26.8%
118,373
+5.3%
0.06%
+26.5%
Q4 2017$15,387,000
+3.7%
112,392
+3.0%
0.05%
-5.8%
Q3 2017$14,839,000
+1631.5%
109,124
+1447.2%
0.05%
+1633.3%
Q2 2017$857,000
+16.4%
7,053
+1.5%
0.00%0.0%
Q1 2017$736,000
+10.5%
6,952
+6.4%
0.00%0.0%
Q4 2016$666,000
+56.0%
6,534
+54.7%
0.00%
+50.0%
Q3 2016$427,000
+64.9%
4,224
+95.6%
0.00%
+100.0%
Q2 2016$259,000
-28.1%
2,159
-34.9%
0.00%
-50.0%
Q4 2015$360,0003,3160.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders